ANTHEMIS NOBILIS (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the ANTHEMIS NOBILIS drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: ANTHEMIS NOBILIS
SUBSTANCE NAME: CHAMOMILE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


ANTHEMIS NOBILIS HUMAN OTC DRUG Details:

Item DescriptionANTHEMIS NOBILIS from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6599_e6ea7416-1dda-43a7-aeff-9ef4a065eca4
PRODUCT NDC: 60512-6599
APPLICATION NUMBER:

Other CHAMOMILE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dasan E&T Co., Ltd.ATORAK CHAMOMILE ATOCARE PURE
HOMEOLAB USA INC.ANTHEMIS NOBILIS
Uriel Pharmacy Inc.Chamomilla 10 Special order